EPO and hyperinsulinemic hypoglycemia, familial, 4: With declining renal mass, patients with CKD lose the ability to produce erythropoietin (EPO) and develop anemia due to low blood iron, inflammation, hemorrhage, EPO resistance, or relative EPO deficiency.